Effect of HFA-flunisolide on peripheral lung inflammation in asthma

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 1, 2003, Pages 58-63

  Hauber, Hans Peter ^a   Gotfried, Mark ^b   Newman, Kenneth ^c   Danda, Rahul ^c   Servi, Ronald J ^b   Christodoulopoulos, Pota ^a   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Pulmonary Associates   (United States)

^c Forest Laboratories   (United States)

Author keywords

Asthma; Eosinophil; Flunisolide; Hydrofluoroalkane; Inflammation; Peripheral airways

Indexed keywords

EOTAXIN; FLUNISOLIDE; FLUORINATED HYDROCARBON; INTERLEUKIN 5;

ADULT; AIRWAY; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASOPHIL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; DRUG FORMULATION; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; LUNG FUNCTION; LYMPHOCYTE; LYMPHOCYTE COUNT; MACROPHAGE; MALE; NEUTROPHIL; PNEUMONIA; PRIORITY JOURNAL; SPIROMETRY; TRANSBRONCHIAL BIOPSY;

EID: 0037662045     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1612     Document Type: Article

References (40)

1. Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol 2002;109:S447-60.
2. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003;111:215-25.
3. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003;111:450-63.
4. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100:44-51.
5. Minshall EM, Hogg JC, Hamid Q. Cytokine mRNA expression in asthma is not restricted to the large airways. J Allergy Clin Immunol 1998;101:386-90.
6. Taha RA, Minshall EM, Miotto D, Shimbara A, Luster A, Hogg JC, et al. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 1999;103:476-83.
7. Carroll N, Cooke G, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J 1997;10:292-300.
8. Faul JL, Tormey VJ, Leonard C, Burke CM, Farmer J, Horne SJ, et al. Lung immunopathology in cases of sudden asthmatic death. Eur Respir J 1997;10:301-7.
9. Christodoulopoulos P, Leung DY, Elliott MW, Hogg JC, Muro S, Toda M, et al. Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J Allergy Clin Immunol 2000;106:479-84.
10. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin JR. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996;154:1505-10.
11. Kraft M, Martin JR, Wilson S, Djukanovic R, Holgate ST. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999;159:228-34.
12. Carroll N, Carello S, Cooke C, James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 1996;9:709-15.
13. Synek M, Anto JM, Beasley R, Frew AJ, Halloway L, Lampe FC, et al. Immunopathotogy of fatal soybean dust-induced asthma. Eur Respir J 1996;9:54-7.
14. Djukanovic R, Wilson JM, Britten KM, Wilson SJ, Walls AF, Roche WR, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145:669-74.
15. Booth H, Richmond I, Ward C, Gardiner PV, Harkawat R, Walters EH. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med 1995;152:45-52.
16. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johanson SA. Effects of the treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-99.
17. Esmailpour N, Hogger P, Rabe KF, Heitmann U, Nakashima M, Rohdewald P. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 1997;10:1496-9.
18. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998;12:1346-53.
19. Richards J, Hirst P, Pitcairn G, Mahashabde S, Abramowitz W, Nolting A, et al. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants. J Aerosol Med 2001;14:197-208.
20. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.
21. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
22. Corren J, Nelson H, Greos LS, Bensch G, Goldstein M, Wu J, et al. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. Ann Allergy Asthma Immunol 2001;87:405-11.
23. Busse WW, Brazinsky S, Jacobsen K, Stricker W, Schmitt K, Vanden Burgt J, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999;104:1212-2.
24. Lilly CM, Nakamura H, Kesselman H, Nagler-Anderson C, Asano K, Garcia-Zepeda EA, et al. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest 1997;99:1767-73.
25. Robinson D, Hamid Q, Ying S, Bentley A, Assoufi B, Durham S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993;148:401-6.
26. Rolfe FG, Hughes JM, Armour CL, Sewell WA. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 1992;77:494-9.
27. Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2003;111:3-22.
28. Cox G, Ohtoshi T, Vancheri C, Denburg JA, Dolovich J, Gauldie J, et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991;4:525-31.
29. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticosteroids. Am J Respir Crit Care Med 1997;156:737-43.
30. Haley KJ, Sunday ME, Wiggs BR, Kozakewich HP, Reilly JJ, Mentzer SJ, et al. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 1998;158:565-72.
31. Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Kimura I. Effects of long-term glucocorticoid therapy on bronchoalveolar lavage cells in adult patients with bronchial asthma. J Asthma 1993;30:309-18.
32. Chanez P, Paradis L, Vignola AM, Vachier I, Vic P, Godard P, et al. Changes in bronchial inflammation of steroid (GCs) dependent asthmatics [abstract]. Am J Respir Crit Care Med 1996;153:212.
33. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils: separation of survival and activation outcomes. J Immunol 1995;154:4719-25.
34. Fukakusa M, Hamid Q, Christodoulopoulos P, Boulet LP, Laviolette M, Chakir J. Effect of inhaled steroids on the expression of chemokine [abstract]. J Allergy Clin Immunol 2002;109:S274.
35. Martin RJ, Cicutto LC, Smith HR, Ballard RD, Szefler SJ. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991;143:351-7.
36. Burke C, Power CK, Norris A, Condez A, Schmekel B, Poulter LW. Luug function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J 1992;5:73-9.
37. Boulet LP, Turcotte H, Laviolette M, Naud F, Bemier MC, Martel S, et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma: influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000;162:1308-13.
38. Holm AF, Godthelp T, Fokkens WJ, Severijnen EA, Mulder PG, Vroom TM, et al. Long-term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis. Clin Exp Allergy 1999;29:1356-66.
39. Yoshimura C, Miyamasu M, Nagase H, Iikura M, Yamaguchi M, Kawanami O, et al. Glucocorticoids induce basophil apoptosis. J Allergy Clin Immunol 2001;108:215-20.
40. Corren J, Nelson H, Greos LS, Bensch G, Goldstein M, Wu J, et al. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. Ann Allergy Asthma Immunol 2001;87:405-11.